diagnostics

23andMe Lays Off 14% Of Workforce Amid Declining DNA Test Sales
23andMe Lays Off 14% Of Workforce Amid Declining DNA Test Sales
Forbes
23andMe
layoffs
diagnostics
Flag link:
23andMe’s First Drug Candidate Licensed to Spanish Pharma Company
23andMe’s First Drug Candidate Licensed to Spanish Pharma Company
Xtalks
23andMe
diagnostics
Almirall
Flag link:
CMS delays clinical lab fee schedule data reporting, cuts capped at 15% for 2021
CMS delays clinical lab fee schedule data reporting, cuts capped at 15% for 2021
Medtech Dive
CMS
devices
diagnostics
clinical laboratory fees
Flag link:
Four ways AI and machine learning will transform healthcare in 2020
Four ways AI and machine learning will transform healthcare in 2020
Pharmaforum
artificial intelligence
machine learning
speech recognitition
clinical trials
robotic surgery
diagnostics
Flag link:
Google AI tool can pinpoint breast cancer better than clinicians, new study suggests
Google AI tool can pinpoint breast cancer better than clinicians, new study suggests
Stat
Google
artificial intelligence
breast cancer
diagnostics
mammograms
Flag link:
Progenics Plans to Seek Approval for Prostate Cancer Imaging Tool Following Phase III Results
Progenics Plans to Seek Approval for Prostate Cancer Imaging Tool Following Phase III Results
BioSpace
Progenics Pharmaceuticals
prostate cancer
PyL
cancer imaging
diagnostics
Flag link:
FDA approves Roche’s MRSA test, allowing for faster screening
FDA approves Roche’s MRSA test, allowing for faster screening
Pharmaforum
FDA
Roche
MRSA
diagnostics
cobas vivoDx
Flag link:
6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Boost
6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Boost
Xconomy
Alzheimer's disease
diagnostics
DiamiR Biosciences
RetiSpec
Flag link:
RightEye Has “Breakthrough” in Its Vision for Parkinson’s Test
RightEye Has “Breakthrough” in Its Vision for Parkinson’s Test
Medical Devices and Diagnostics Industry
RightEye
RightEye Vision System
diagnostics
Parkinson's Disease
Flag link:
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
Xconomy
Veracyte
NanoString
diagnostics
Flag link:
Japan Approves Genetic Testing For Breast Cancer Treatment
Japan Approves Genetic Testing For Breast Cancer Treatment
Forbes
Japan
genetic testing
breast cancer
BRACAnalysis CDx
Myriad Genetics
diagnostics
Flag link:
FDA grants breakthrough status to AI-based gastric cancer diagnostic
FDA grants breakthrough status to AI-based gastric cancer diagnostic
Medtech Dive
gastric cancer
AI Medical Service
diagnostics
FDA
artificial intelligence
devices
Flag link:
Genfit trumpets new NASH blood biopsy data
Genfit trumpets new NASH blood biopsy data
Pharmaforum
Genfit
NASH
diagnostics
liquid biopsy
Flag link:
FDA Gives Nod for Breakthrough HIV Test
FDA Gives Nod for Breakthrough HIV Test
Medical Devices and Diagnostics Industry
Vela Diagnostics
HIV
diagnostics
FDA
Sentosa SQ HIV Genotyping Assay
Flag link:
The emergence of laboratory benefits managers: PBM déjà vu?
The emergence of laboratory benefits managers: PBM déjà vu?
Stat
diagnostics
laboratory benefits managers
LBMs
PBMs
insurers
Flag link:
Blood Test Can Detect Breast Cancer 5 Years Before Symptoms Occur
Blood Test Can Detect Breast Cancer 5 Years Before Symptoms Occur
Medical Devices and Diagnostics Industry
breast cancer
diagnostics
tumor-associated antigens
Flag link:
Biocept Files for $27 Million Offering
Biocept Files for $27 Million Offering
CP Wire
Biocept
liquid biopsy
diagnostics
oncology
Flag link:
Illumina's Next Big Move: Distributed Diagnostics
Illumina's Next Big Move: Distributed Diagnostics
Motley Fool
Illumina
genome sequencing
distributed diagnostics
diagnostics
Flag link:
CMS proposes lifting restrictions on NGS cancer testing
CMS proposes lifting restrictions on NGS cancer testing
Biopharma Dive
CMS
next generation sequencing
diagnostics
oncology
cancer
Medicare
Flag link:
Diagnostics specialists win the US device approval race
Diagnostics specialists win the US device approval race
EP Vantage
devices
diagnostics
Roche
FDA
Flag link:

Pages